Vibran 10% Glucose Injection

Adult administration

Inject 20 to 500 mL intravenously. The rate of intravenous infusion should not exceed 0.5 g/kg per hour as glucose. Use an appropriate amount for dissolving or diluting the injection. Adjust according to age and symptoms.

Care should be taken to avoid glass shards entering the injection solution when using this drug in ampoules. Extra caution is required when administering to children or the elderly. Patients receiving intravenous glucose should be aware that vitamin B1 may be rapidly consumed, leading to severe deficiency symptoms. This medication should not be administered to patients with certain conditions such as dehydration, fluid overload, hyperglycemia, acidosis, hypokalemia, hyperosmolar coma, or intolerance to glucose. It must not be used in patients with anuria or hepatic coma, or those allergic to this medication. It should be administered cautiously to patients who have deficiencies of potassium, phosphorus, or magnesium, or conditions such as renal failure, heart failure, nutritional deficiencies, or sepsis. Rapid or large infusions may result in electrolyte imbalances, dehydration, hyperosmolarity, and elevated substance levels in the blood, thus caution is advised. Long-term use of this medication may affect insulin secretion, and insulin should be provided as needed. During pregnancy, it should only be used when absolutely necessary, considering the risk to the fetus, and care should be taken with the glucose level of the mother and newborn during delivery. Newborns or premature infants are at higher risk of hypoglycemia or hyperglycemia, and their blood glucose levels should be closely monitored. Elderly patients, due to diminished physical function, should be used with extra caution. Overdosage may lead to hyperglycemia or diabetes symptoms, possibly requiring insulin treatment. It is advisable not to use this drug for subcutaneous injections, and any leftovers after opening should be discarded immediately. To reduce the risk of infection during injection, pay attention to hygiene; it should be warmed to body temperature when cold. When mixing with other medications, check for potential chemical interactions and side effects, and administer carefully. Also, take care not to introduce air bubbles that might lead to air embolism.

Mild side effects

• Fever
• phlebitis
• thrombosis
• blood leakage
• injection site pain
• uremia
• electrolyte imbalance
• congestion
• pulmonary edema
• hyperglycemia

This medication should be stored in a sealed container to prevent air and moisture exposure, at room temperature. Proper storage will help maintain the drug's effectiveness over time.

Appearance

A colorless and transparent infusion injection filled in a polyethylene container.

Package unit

Bottle - 500 milliliters/bottle, Bottle - 1000 milliliters/bottle